office and Duties. (a) During the Term, the Executive shall serve as the
President and Chief
Financial Executive Officer of the Company, as well as in any other position to which the Executive is appointed by the Company's Board of Directors (the "Board"). The Executive shall report to the Board and
the Company's Chief Executive Officer or his designee(s) and shall perform such duties and have such responsibilities as the Board
or the Company's Chief Executive Officer or his designee(s) may determine from time to
...time and which are consistent with Executive's then current position with the Company. (b) During the Term, the Company shall cause the Executive to be elected or appointed to the Board and the Executive agrees to serve in such capacity without additional compensation; provided however, that during any period that the Company's stock is publicly traded, the Company's obligation under this Section will be limited to nominating the Executive to the Board. (c) During the Term, the Executive shall devote substantially all of his working time, energy, business time and his skill and best efforts to the performance of his duties hereunder in a manner that will faithfully and diligently further the business and interests of the Company. (c) (d) During the Term, the Executive shall not be engaged in any business activity which, in the reasonable judgment of the Board, conflicts with the Executive's duties hereunder, whether or not such activity is pursued for pecuniary advantage. Should the Executive wish to provide any services to any other person or entity other than the Company or to serve on the board of directors of any other entity or organization, the Executive shall submit a written request to the Board for consideration and approval by the Board in its sole discretion. discretion; provided, however, that the Company acknowledges and agrees that the Executive currently provides services to the following companies and that the Executive may continue to provide such services during the Term (provided that, without the Board's prior written consent, the Executive's average monthly time commitment to any one of such companies shall not increase beyond the level of his average monthly time commitment to such company as of the Effective Date): Novum Pharma, LLC and affiliated entities, Novos Growth, LLC, Champion Investments, LLC, Athilio Pharma, LLC, Underhill Pharma, LLC, Beaver-Visitec International, Vault Pharma and Bright Path Pharmaceuticals.
View More
office and Duties. (a) During the Term, the Executive shall serve as the
President and Chief
Financial Executive Officer of the
Company, Company and the President and Chief Executive Officer of Assertio Holdings, Inc. ("Parent"), as well as in any other position to which the Executive is appointed by
the Company's Parent's Board of Directors (the "Board"). The Executive shall report to the Board and
the Company's Chief Executive Officer or his designee(s) and shall perform such duties and have such responsibilitie
...s as the Board or the Company's Chief Executive Officer or his designee(s) may determine from time to time and which are consistent with the Executive's then current position with positions hereunder. (b) During the Company. (b) Term, the Company shall cause the Executive to be nominated to the Board to the extent that the Executive is up for re-election. (c) During the Term, the Executive shall devote substantially all of his working time, energy, the Executive's business time and the Executive's skill and best efforts to the performance of his the Executive's duties hereunder in a manner that will faithfully and diligently further the business and interests of the Company. (c) (d) During the Term, the Executive shall not be engaged in any business activity which, in the reasonable judgment of the Board, conflicts with the Executive's duties hereunder, whether or not such activity is pursued for pecuniary advantage. Should the Executive wish to provide any services to any other person or entity other than the Company or to serve on the board of directors of any other entity or organization, the Executive shall submit a written request to the Board for consideration and approval by the Board in its sole discretion. discretion; provided, however, that the Company acknowledges and agrees that the Executive currently provides services to the following companies and that the Executive may continue to provide such services during the Term (provided that, without the Board's prior written consent, the Executive's average monthly time commitment to any one of such companies shall not increase beyond the level of his average monthly time commitment to such company as of the Effective Date): Novum Pharma, LLC and its affiliated entities, Novos Growth, LLC and its affiliated entities, Champion Investments, LLC, Athilio Pharma, LLC and its affiliated entities, Underhill Pharma, LLC, Beaver-Visitec International, Vault Pharma and Bright Path Pharmaceuticals.
View More